Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness”
Titel:
Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness”
Auteur:
Lim, Bora Seth, Sahil Yam, Clinton Huo, Lei Fujii, Takeo Lee, Jangsoon Bassett, Roland Nasser, Sara Ravenberg, Lisa White, Jason Clayborn, Alyson Guerra, Gil Litton, Jennifer K. Damodaran, Senthil Layman, Rachel Valero, Vicente Tripathy, Debasish Lewis, Michael Dobrolecki, Lacey E. Lei, Jonathan Candelaria, Rosalind Arun, Banu Rauch, Gaiane Zhao, Li Zhang, Jianhua Ding, Qingqing Symmans, W. Fraser Chang, Jeffrey T. Thompson, Alastair M. Moulder, Stacy L. Ueno, Naoto T.